Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 09, 2025 10:28 ET | Source: Research and Markets

Pharma and Biotech Preclinical Stage Partnering Terms and Agreements Analysis Report 2025: An Indispensable Resource for Business Development, Legal, and Financial Professionals

Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2025" report has been added to ResearchAndMarkets.com's offering. The...
May 08, 2025 10:55 ET | Source: Research and Markets

Contract Research and Manufacturing Services (CRAMS) Business Report 2025: Market to Reach $211.4 Billion by 2030, Fueled by Growing Demand for Biologics and Biosimilars

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Contract Research and Manufacturing Services (CRAMS) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The...
May 07, 2025 09:24 ET | Source: Research and Markets

High Content Screening Market Global Forecasts 2025-2030 with Danaher, Revvity, BD, Carl Zeiss, Merck, and Thermo Fisher Scientific Dominating the $2.19 Billion Market

Dublin, May 07, 2025 (GLOBE NEWSWIRE) -- The "High Content Screening Market by Product & Services (Instrument (Cell Imaging, Analysis System), Consumables (Reagents & Assay Kits,...
May 07, 2025 09:00 ET | Source: e-therapeutics plc

e-therapeutics Presents New Data Supporting ETX‑312 as a Differentiated and Disease-Modifying Near-Clinic Treatment for MASH

LONDON, May 07, 2025 (GLOBE NEWSWIRE) -- e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, today announced it will...
April 16, 2025 07:47 ET | Source: Research and Markets

KRAS Inhibitors Market Research and Forecasts 2025-2030: Lumakras, Krazati, Dupert, Anfangning Drug Sales, Patent, Price & Clinical Trials Insights

Dublin, April 16, 2025 (GLOBE NEWSWIRE) -- The "KRAS Inhibitors Market, Drug Sales, Patent, Price & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering. ...
April 08, 2025 11:44 ET | Source: Research and Markets

LAG-3 Targeting Therapy Market & Clinical Trials Insight Report 2030: Insight on 35+ LAG-3 Targeted Therapies In Clinical Trials

Dublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "LAG-3 Targeting Therapy Market, Drug Dosage, Patent, Sales & Clinical Trials Insight 2030 Report" report has been added to ...
April 02, 2025 08:37 ET | Source: Research and Markets

STAT3 Inhibitors Market Analysis & Clinical Trials Report 2025-2028: Innovation in Drug delivery and Formulation Techniques - Opportunities May Expand Beyond Oncology

Dublin, April 02, 2025 (GLOBE NEWSWIRE) -- The "STAT3 Inhibitors Market Opportunity & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. The market for...
March 24, 2025 05:02 ET | Source: Research and Markets

Global CRISPR Cas9 Market Opportunity & Clinical Trials Outlook 2024-2029: 25 Therapies Currently in Trial - Many will Penetrate the Market in the Imminent 5-7 Years

Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Global CRISPR Cas9 Market Opportunity & Clinical Trials Outlook 2029" report has been added to ResearchAndMarkets.com's offering. Antecedently,...
March 20, 2025 10:24 ET | Source: Research and Markets

Next-Gen Immunotherapy: Trispecific Antibodies Show 260x Potency Over Traditional Treatments

Dublin, March 20, 2025 (GLOBE NEWSWIRE) -- The "Trispecific Antibodies Clinical Trials, Fast Track Status, Technology Platforms & Market Opportunity Outlook 2025" report has been added to ...
March 19, 2025 07:21 ET | Source: Research and Markets

PROTAC Targeted Protein Degraders Market Landscape Report 2024-2027: 90 Drugs in Clinical Trial, Insights on 10 Platforms, First 12 Months & First 5 Years Market Size Estimates Since Approval

Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- The "Global PROTAC Targeted Protein Degraders Market Opportunity & Clinical Trials Insight 2027" report has been added to ResearchAndMarkets.com's...

Next Page keyboard_arrow_right